Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Kempharm Inc
(NQ:
KMPH
)
6.040
USD
-0.040 (-0.66%)
Official Closing Price
Updated: 7:48 PM EST, Jan 21, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
688,100
Open
6.000
Bid (Size)
5.950 (1)
Ask (Size)
6.020 (1)
Prev. Close
6.080
Today's Range
5.880 - 6.115
52wk Range
0.1800 - 6.270
Shares Outstanding
15,758,411
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
KemPharm’s KP415 and Serdexmethylphenidate (SDX) Prodrug to be Featured in Multiple Sessions at the 2021 APSARD Virtual Conference
January 14, 2021
From
GlobeNewswire News Releases
KemPharm Participating in BIO @ JPM and Fierce JPM Week 2021 Virtual Events During “J.P. Morgan Week 2021”
January 13, 2021
From
GlobeNewswire News Releases
Performance
YTD
+7.86%
+7.86%
1 Month
+7.86%
+7.86%
3 Month
+7.86%
+7.86%
6 Month
+7.86%
+7.86%
1 Year
+1413.41%
+1413.41%
More News
Read More
KemPharm Announces Pricing of $50 Million Public Offering of Common Stock and Warrants and Uplisting to The Nasdaq Capital Market
January 08, 2021
From
GlobeNewswire News Releases
KemPharm Announces 1-for-16 Reverse Stock Split
December 23, 2020
From
GlobeNewswire News Releases
KemPharm Files IND for KP879 for the Treatment of Stimulant Use Disorder
December 22, 2020
From
GlobeNewswire News Releases
KemPharm Participates in KP415 Late-Cycle Communication Meeting with FDA
December 02, 2020
From
GlobeNewswire News Releases
REMINDER: KemPharm and Corium to Co-Host “KP415 Market Opportunity and Commercialization Strategy” Investor Event
November 30, 2020
From
GlobeNewswire News Releases
KemPharm Provides Update on Development Pipeline
November 23, 2020
From
GlobeNewswire News Releases
KemPharm and Corium to Co-Host “KP415 Market Opportunity and Commercialization Strategy” Investor Event
November 18, 2020
From
GlobeNewswire News Releases
KemPharm Reports Third Quarter 2020 Financial Results
October 29, 2020
From
GlobeNewswire News Releases
KemPharm Postpones Special Meeting of Stockholders, Announces Date for Q3 2020 Results Call
October 26, 2020
From
GlobeNewswire News Releases
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.